Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.063 | 0.7 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |